WARNING: “Buffett Indicator” flashing for first time in 50 years

Warren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indicates the Oracle of Omaha is quietly preparing for a historic market crash. His most reliable crash indicator - the "Buffett indicator" - just flashed red for the first time in 25 years.

Take these 4 steps today to protect your retirement NOW

Michael P. Spears net worth and biography

Michael Spears Biography and Net Worth

SVP of Insulet

Michael Spears serves as Senior Vice President - Regulatory Affairs and Compliance of the Company. Mr. Spears has served as our Senior Vice President Regulatory Affairs and Compliance since May 2019. From February 2017 to May 2019, Mr. Spears served as our Senior Vice President, Quality and Regulatory Affairs. From July 2015 to February 2017, Mr. Spears served as our Senior Vice President, Quality, Regulatory and Clinical Affairs. From 2011 to July 2015, Mr. Spears served as Vice President, Quality Assurance & Regulatory Affairs at Covidien plc, which was acquired by Medtronic in 2015. From 2006 to 2011, Mr. Spears served as Vice President, Quality Assurance at Covidien. From 1999 to 2006, he had several years of progressively broader assignments at Covidien, then known as Tyco Healthcare. Mr. Spears also served as a paralegal at two law firms over an 11-year period. He earned his Bachelor of Arts from the University of Tennessee and a Master of Business Administration from the University of South Carolina.

What is Michael P. Spears' net worth?: The estimated net worth of Michael P. Spears is at least $2.34 million as of November 4th, 2022. Mr. Spears owns 8,792 shares of Insulet stock worth more than $2,343,683 as of December 21st. This net worth estimate does not reflect any other assets that Mr. Spears may own. Learn More about Michael P. Spears' net worth.
How do I contact Michael P. Spears?: The corporate mailing address for Mr. Spears and other Insulet executives is 100 NAGOG PARK, ACTON MA, 01720. Insulet can also be reached via phone at (978) 600-7000 and via email at [email protected]. Learn More on Michael P. Spears' contact information.
Has Michael P. Spears been buying or selling shares of Insulet?: Michael P. Spears has not been actively trading shares of Insulet during the last ninety days. Most recently, Michael P. Spears sold 13,658 shares of the business's stock in a transaction on Friday, November 4th. The shares were sold at an average price of $308.99, for a transaction totalling $4,220,185.42. Following the completion of the sale, the senior vice president now directly owns 8,792 shares of the company's stock, valued at $2,716,640.08. Learn More on Michael P. Spears' trading history.
Who are Insulet's active insiders?: Insulet's insider roster includes Charles Alpuche (COO), Eric Benjamin (SVP), Luciana Borio (Director), Bret Christensen (EVP), Sally Crawford (Director), John Fallon (Director), Mark Field (SVP and Chief Technology Officer), James Hollingshead (CEO), Dan Manea (SVP), Wayde McMillan (CFO), Shacey Petrovic (CEO), Timothy Scannell (Director), Prem Singh (SVP), and Michael Spears (SVP). Learn More on Insulet's active insiders.
Are insiders buying or selling shares of Insulet?: In the last twelve months, insiders at the medical instruments supplier sold shares 6 times. They sold a total of 26,455 shares worth more than $4,779,816.91. The most recent insider tranaction occured on December, 10th when CAO Lauren Budden sold 915 shares worth more than $252,192.30. Insiders at Insulet own 0.5% of the company. Learn More about insider trades at Insulet.
Information on this page was last updated on 12/10/2024.

Michael P. Spears Insider Trading History at Insulet

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/4/2022	Sell	13,658	$308.99	$4,220,185.42	8,792
4/16/2020	Sell	1,449	$193.76	$280,758.24	11,447
2/27/2020	Sell	13,627	$182.01	$2,480,250.27	13,560
8/15/2019	Sell	4,153	$146.12	$606,836.36	22,626
8/14/2018	Sell	5,043	$86.08	$434,101.44
6/13/2018	Sell	7,496	$100.00	$749,600.00
5/30/2018	Sell	8,071	$95.00	$766,745.00
5/24/2018	Sell	8,671	$90.00	$780,390.00
5/18/2018	Sell	7,774	$87.77	$682,323.98
5/15/2018	Sell	8,114	$86.64	$702,996.96
5/16/2017	Buy	2,500	$40.59	$101,475.00

Michael P. Spears Buying and Selling Activity at Insulet

Insulet Company Overview

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Today's Range

Now: $266.57

$256.56

$270.70

50 Day Range

MA: $253.81

$229.13

$275.70

2 Week Range

Now: $266.57

$160.19

$279.77

Volume

1,465,981 shs

Average Volume

763,584 shs

Market Capitalization

$18.70 billion

P/E Ratio

45.65

Dividend Yield

N/A

Beta

1.21

First JFK… next Elon?

From Porter & Company | Ad

Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.

I share with you in this special investigative documentary.